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less potent opioids, and potent opioids.
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Purpose: Previous studies have suggested that placebo injections
into the knee joint can relieve pain in patients with knee osteo-
arthritis (KOA). It is now clear that several different types of pain
and pain mechanisms can occur in KOA: some patients have sig-
niﬁcant pain sensitisation, and a generalised pain problem compli-
cating any peripheral, nocioceptive cause. It is also known that some
20% of people who have a knee replacement do not obtain good pain
relief. We wanted to investigate the possible value of an intra-
articular injection of either a placebo or a local anaesthetic as an aid
to sorting out pain mechanisms, and helping patients and
their doctors decide whether surgery might be a good treatment
option.
Methods: The study was approved by the local ethics committee. 20
patients attending a rheumatology clinic because of bilateral, painful
KOA were recruited and gave signed, informed consent. Demographic
data was collected, including a full pain history, and the knees were
examined. Each patient then had two injections into the knee which
was causing them most pain (the index knee), with an interval of two
weeks between each injection. They were randomised to having intra-
articular Marcaine or an equivalent volume of saline ﬁrst, and the
alternative injection second, in a double blind study design. Prior to
each injection pain questionnaires were administered, including the s-
LANSS to assess neuropathic pain, and the HADs to assess the degree of
anxiety and depression. Following each injection pain scores were
collected daily in relation to both knees, for a two week period. 3
months after the end of the study all patients were recalled for follow-
up at which point they were asked about their satisfactionwith being in
the study, their preference for the ﬁrst or second injection, the overall
amount of symptom relief, whether the contralateral knee had
improved during the study, and whether being in the study had helped
them understand their pain better and decide whether surgery was for
them or not.
Results: 13 women and 7 men were recruited to the study, 14 were
Caucasian, 4 Indian and 2 Samoan, their mean age was 63 years (range
47-81). All were on some medication for their painful knee OA (18
simple analgesics, 14 NSAIDs) and they were suffering from a variety of
co-morbidities. Baseline scores indicated that 7 were complaining of
widespread pain problems in addition to knee pain, 4 had s-LANSS
scores of 12 or greater indicative of neuropathic-like pain, and 3 had a
high HADs score indicative of signiﬁcant anxiety/depression.10 patients
had Marcaine ﬁrst and 10 Saline ﬁrst. Most patients reported some pain
relief after each injection, but there were no signiﬁcant differences in
pain scores after the Marcaine or Saline: pain relief was greater after
Marcaine than Saline in 7 people, greater after Saline than Marcaine in8, and in the remaining 5 the pain relief scores were almost identical
after each injection. The total pain scores at the end of each two week
observation period showed that scores were lower at the end of the
second period than at the end of the ﬁrst, irrespective of whether
Marcaine or Saline was injected ﬁrst, and at the three month assess-
ment 13 said they favoured the second injection and 7 the ﬁrst. Four
patients reported improvement in pain in the contralateral knee. There
was no apparent difference in the response to Saline or Marcaine in
those with or without widespread pain, neuropathic pain, or anxiety/
depression. However, satisfaction with the study did differ in these
groups: fewer of those with widespread pain, neuropathic pain and
anxiety or depression reported that they got better than those without
any such features (5 of 9 compared with 9 of 11 respectively). 19 or the
20 said they were pleased to have had the chance to take part, 13 said
that it had helped greatly with their understanding of their pain
problem and 9 said it had inﬂuenced their decision about surgical
intervention.
Conclusions: There was very little difference in the pain response to
intra-articular Marcaine or Saline in this small pilot placebo study of
intra-articular injections in patients with KOA. This suggests that much
of the response to any intra-articular therapy is placebo related. The
study is too small to reach any conclusions about the value of this
approach in sorting out different pain syndromes, but we believe it
likely that it could be a helpful research tool, and out data strongly
suggest that it can be a valuable aid to doctors and patients in gaining
understanding of the pain, and in coming to appropriate treatment
decisions.
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Purpose: Curcuminoids are natural products with potent anti-inﬂam-
matory and antioxidant properties. There have been a number of
reports on the analgesic effects of curcuminoids in clinical trials, yet
data have not been fully conclusive. The objective of this study was to
provide the highest level of evidence on the efﬁcacy of curcuminoids in
patients with painful conditions through meta-analysis of data from
randomized controlled trials (RCTs).
Methods: A systematic review and meta-analysis was conducted using
data reported by RCTs. The primary efﬁcacy measure was pain intensity
or algofunctional status. Treatment effect was summarized with
standardized mean difference (SMD) calculated from differences in
means of pain measures between treatment and control groups using a
random-effects model.
Results: A total of 8 RCTs met our inclusion criteria, that included 606
randomized patients with diffrent painful conditions (osteoarthritis,
rheumatoid arthritis, ﬁbromyalgia). Curcuminoids were found to sig-
niﬁcantly reduce pain (SMD: -0.57, 95% CI: -1.11 to -0.03, p ¼ 0.04). This
pain-relieving effect was found to be independent of administered dose
and duration of treatment with curcuminoids, and was free from pub-
lication bias. Curcuminoids were safe and well tolerated in all evaluated
RCTs.
Conclusions: This meta-analysis of RCTs showed that supplementation
with curcuminoids is a safe and effective strategy to reduce pain severity.
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Purpose: The history of oral Chinese herbal medicine is ancient, and the
therapy is considered to have analgesic effects for patients with knee
osteoarthritis (OA). We conducted a systematic review and meta-
analysis of the evidence to evaluate the efﬁcacy for pain relief of oral
Chinese herbal medicine in patients with knee OA.
